Cerus Corp (CERS) stock

CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3022% below fair value

$1.94−0.18 (-8.49%)

Close on Nov 12, 2026Market cap $390.96MP/E –Yield –

Cerus operating margin

Operating margin is operating income as a percentage of revenue.

Cerus's operating margin for the twelve months ending Sep 30, 2026 was -1.0%. For fiscal 2025 it was -3.7%, against -7.1% the year before. The highest annual figure on record is -3.7% in fiscal 2025.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-3.7%	+3.4
FY2024	Dec 31, 2024	-7.1%	+9.0
FY2023	Dec 31, 2023	-16.1%	+2.0
FY2022	Dec 31, 2022	-18.1%	+12.6
FY2021	Dec 31, 2021	-30.7%	+20.4
FY2020	Dec 31, 2020	-51.1%	+19.6
FY2019	Dec 31, 2019	-70.6%	+1.7
FY2018	Dec 31, 2018	-72.3%	+39.8
FY2017	Dec 31, 2017	-112.1%	+44.4
FY2016	Dec 31, 2016	-156.5%	+22.0
FY2015	Dec 31, 2015	-178.5%	−56.3
FY2014	Dec 31, 2014	-122.2%	−50.8
FY2013	Dec 31, 2013	-71.4%	−24.3
FY2012	Dec 31, 2012	-47.0%	+1.2
FY2011	Dec 31, 2011	-48.2%	+20.9
FY2010	Dec 31, 2010	-69.1%	+63.5
FY2009	Dec 31, 2009	-132.5%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	0.7%	−1.7
Q2 FY2026	Jun 30, 2026	-3.2%	+3.3
Q1 FY2026	Mar 31, 2026	-0.7%	+12.9
Q4 FY2025	Dec 31, 2025	-0.8%	+48.1
Q3 FY2025	Sep 30, 2025	2.3%	+90.7
Q2 FY2025	Jun 30, 2025	-6.5%	+75.0
Q1 FY2025	Mar 31, 2025	-13.5%	+84.9
Q4 FY2018	Dec 31, 2018	-48.8%	+18.0
Q3 FY2018	Sep 30, 2018	-88.3%	+26.3
Q2 FY2018	Jun 30, 2018	-81.5%	+88.6
Q1 FY2018	Mar 31, 2018	-98.5%	+159.8
Q4 FY2017	Dec 31, 2017	-66.8%	+82.4
Q3 FY2017	Sep 30, 2017	-114.7%	–
Q2 FY2017	Jun 30, 2017	-170.1%	–
Q1 FY2017	Mar 31, 2017	-258.3%	–
Q4 FY2016	Dec 31, 2016	-149.2%	–